1Muschter R. Free-Beam and contact laser caogulation.J Endourol,2003,17: 579- 585.
2Costello A J, Bowsher W G, Bolton D M, et al. Laser ablation of the prostate in patients with benign prostatic hypertrophy. BrJ Urol, 1992, 69: 603-608.
3Narayan P, Tewarl A, Aboself S, et al. A randomized study comparing visual laser ablation and transurethral evaporation of prostate in the management of benign prostatic hyperplasia. J Urol, 1995, 154: 2083-2088.
4Reek C, Conrad S, Heinzer H, et al. Side-fire laser coagulation of the prostate with the Neodymium: YAG laser. Long term outcome. Urology A, 2001, 40:127-132.
5Sengor F, Gurdal M, Tekin A, et al. Neodymium:YAG visual laser ablation of the prostate: 7 years of experience with 230 patients. J Urol, 2002, 167:184-187.
6Gujral S, Abrams P, Donovan J L, et al. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in mem with chronic urinary retention: the clasp study. J Urol, 2000, 164:59-64.
7Donovan J L, Peters T J, Neal D E, et al. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: the clasp study. J Urol, 2000, 164: 65-70.
8Shingleton W B, Renfroe L D, Kolski J M, et al. A randomized prospective study of transurethral electrovaporization vs laser ablation of the prostate in men with benign prostatic hypertrophy. Scand J Urol Nephrol, 1998, 32: 266-269.
9Khalek M A, Hammady S E, Ibrahiem E H. A 4-year follow-up of a randomized prospective study comparing transurethral eletrovaporization of the prostate with Neodymium: YAG laser therapy for treating benign prostatic hyperplasia. BJU Int, 2003, 91: 801-805.
10Gottfried W H, Krautschick A, Hefty R, et al. Transurethral laser ablation of the prostate(TULAP). Preliminary results in 188 patients. Urology A, 1995, 34:132-137.
